Impaired lipid metabolism in diabetic patients can lead to cardiovascular complications. Poor glycaemic control is associated with a significant increase in the risk of both patient’s morbidity and mortality. An early intervention to regulate circulating lipids has been found to lower the risk of cardiovascular problems and death. Glycated hemoglobin (HbA1c) is a reliable indicator of rising blood sugar levels. This hospital based observational study was conducted in the Department of Medicine, Sher-E-Bangla Medical College Hospital, Barisal from October 2014 to March 2015 over a period of 6 month to determine the correlation of glycemic control and lipid profile in patients with type 2 diabetes. A total of 110 type 2 diabe- tes mellitus(DM) patients of both sexes admitted to the Deapartment of Medicine of Sher-E- Bangla Medical College Hospital, Barisal, were recruited for this study. Following standard procedures and protocols, fasting blood sugar (FBS), blood sugar two hours after breakfast, Glycosylated Hemoglobin (HbA1c) and fasting lipid profile were measured. The age of respondents ranged from 34 to 70 years with the mean age of 54.35}8.02 years. Among the patients male were 70 (63.6%) and female were 40 (36.4%). Mean age at diagnosis of DM and duration of DM was 47.07}6.03 years and 7.27}3.41 years, respectively. Mean body mass index (BMI), FBS and HbA1c were 25.02}5.22 kg/m2, 8.06}2.01 mmol/L and 8.34}1.9 % respectively. Significant positive correlation of HbA1c and FBS with BMI, total cholester- ol(TC), triglyceride(TG), low density lipoprotein(LDL-C) and negative correlation with high density lipoprotein (HDL-C) was found. Significantly higher TC, TG and LDL-C and lower HDL-C were found in poor glycemic control (HbA1c ≥ 7) group than good glycemic control (HbA1c < 7 ) group. The results of this study showed that , higher levels of glycemic parame- ters are significantly associated with dyslipidemia. These findings also indicate that HbA1c can be utilized for screening of high risk diabetic patients for early diagnosis of dyslipidemia and timely intervention with lipid lowering drugs. BSMMU J 2021; 14(4): 138-143

Background: Non-alcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome (MS) such as hypertension, type 2 diabetes mellitus, dyslipidaemia and obesity. NAFLD is considered as hepatic manifestation of metabolic syndrome (MS). Objectives: The aim of this study was to see the pattern of lipid profile and blood pressure in NAFLD patients. Materials and methods: This cross sectional study was carried out in the department of gastroenterology, BSMMU, Dhaka, Bangladesh from October 2016 to March 2017. A total of 100 patients included in this study underwent abdominal ultrasonography after excluding known case of liver disease with other etiology. Results: The study population were categorized as NAFLD and normal group on the basis of abdominal ultrasonography. NAFLD and normal subjects were 55% and 45% respectively. The mean age was 41.34 + 10.88 years. Male were 62% and 38% were female.40% of study subjects were overweight, 23% were obese and 37% had normal bodyweight. Body mass index (BMI) was higher in NAFLD group; 25.10 ± 1.75 vs 21.64 ± 2.62 , P < 0.001). Dyslipidemia was present in 47% of study population. Total cholesterol (TC) (195.5±45.98 vs 140.33±47.86 mg/dl, P < 0.001), Low density lipoprotein-cholesterol (LDL-C) (120.28±43.95 vs 95.15±44.90 mg/dl, P < 0.001) and Triglyceride (TG) (230.50 ± 48.96 vs 148.40±46.43 mg/dl , P < 0.001) was higher and High density Lipoprotein (HDL) (32.69±5.49 vs 39.91±5.74 mg/dl, P < 0.001) was lower in NAFLD group in comparison to normal group. Systolic and diastolic blood pressure (BP) was also significantly higher in NAFLD group (135±12 vs 121±9 mm Hg , P < 0.001) and 82±4 vs 74±3 mm Hg (P < 0.001) respectively. Conclusion: Higher prevalence of dyslipidemia was found in NAFLD patients. TC, LDL-C , TG and blood pressure was significantly higher in NAFLD patient in comparison to normal group. J Shaheed Suhrawardy Med Coll 2021; 13(1): 68-74